Ethypharm

Ethypharm is a leading international specialty pharmaceutical company with strong European roots. It manufactures and supplies essential medicines, focusing on hospital injectables, CNS therapies (severe pain and addiction), and internal medicine. Committed to improving patients' lives and making a positive impact on society and the environment, Ethypharm operates in 68 countries, marketing directly in Europe, the UK, and China, and through strategic partnerships across EMEA, NA, LATAM, and APAC.

Ethypharm runs six manufacturing sites in France, the UK, Spain, and China, specializing in injectables and complex oral solid forms. The company offers global partnerships for in-licensing, out-licensing, and distribution, along with CDMO capabilities, manufacturing various dosage forms like ampoules, vials, pre-filled syringes, bags, oral liquids, and oral solid doses.

Ethypharm actively seeks licensing, distribution, and acquisition opportunities, particularly in hospital injectables, CNS, and internal medicine.
Visit www.ethypharm.com for more.